---
$id: https://graph.org.ai/products/commodity/51171833
$type: Product
source: UNSPSC
code: "51171833"
title: "Bromopride"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bromopride

**UNSPSC Code**: 51171833
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine antagonist and antiemetic agent with the molecular formula C14H22BrN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75473V2YZK, chemically known as o-anisamide, 4-amino-5-bromo-n-(2-(diethylamino)ethyl)- but generally known as bromopride, which bears US NIH Compound Identifier 2446. Bromopride most often comes in base and hydrochloride forms. European Medicines Agency schedules Bromopride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05921MIG. The term BROMOPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules bromopride in its Anatomical Therapeutic Chemical (ATC) Classification. BROMOPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bromopride under HS 29242995 and SITC 51479. As of Q4 2014, BROMOPRIDE remains the US FDA Preferred Term for this commodity. Bromopride bears US NLM identifiers UMLS ID C0054129 and NCI Concept Code C73035. SMILES: BRC1CC(C(=O)NCCN(CC)CC)C(OC)CC1N.

